Achieve compliance through year-end pharma annual requirements

Bio Pharma Dive

Receive drug conversion and submission services by our expert staff, to remain compliant with the FDA

Hidden compliance risks for life sciences companies

Pharma Phorum

The life sciences history industry has some unique challenges when it comes to compliance. But if you think third party compliance risks are bad, don’t take your eye off fourth and fifth parties, says Allan Matheson.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

COVID-19: Compliance to household mixing restrictions in England decreased with each lockdown

Scienmag

Latest News Compliance COVID19 decreased England household lockdown mixing restrictionsHousehold mixing significantly decreased in the first lockdown in England and remained relatively low in the second lockdown, but increased during the third lockdown, reports a study published in Scientific Reports. The authors observed that the increase in household mixing by mid-February 2021 during the third lockdown coincided with the wider COVID-19 vaccine rollout across England. […].

5 HIPAA Compliance Tips For Healthcare Professionals

Pharma Mirror

They can deal with other healthcare franchises, which also need compliance. There are more reasons why health professionals should have a HIPAA compliance program in their clinics and offices.

Exploring new technology integrations to make research compliance altogether better

Forte Research Systems®

Clinical Research Technologies Compliance and Regulatory Efficient Clinical TrialsSince joining forces a year ago, Advarra and Forte have worked to ensure altogether better research, integrating Advarra’s CIRBI platform and Forte eReg.

FDA Pharmaceutical Quality Management Webinar: Risk Management and Regulatory Compliance, They are Complementary, Not Incompatible – ResearchAndMarkets.com

BioTech 365

FDA Pharmaceutical Quality Management Webinar: Risk Management and Regulatory Compliance, They are Complementary, Not Incompatible – ResearchAndMarkets.com FDA Pharmaceutical Quality Management Webinar: Risk Management and Regulatory Compliance, They are Complementary, Not Incompatible – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Quality Management – … Continue reading → Business Wire

Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split

BioTech 365

Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split CHICAGO–(BUSINESS WIRE)–Exicure, Inc.

A Message to Pharma CIOs: Optimizing Salesforce Improves Security and Compliance

Pharma Phorum

However, issues like compliance, governance and security often are. These problems tend to be the most severe in the oldest and largest Salesforce orgs, and can result in slow performance, reduced agility, sluggish adoption, misalignment and even compliance and security issues.

Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule

BioTech 365

Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule VANCOUVER and MINNEAPOLIS, May 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced … Continue reading → GlobeNewswire

Titan Medical Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

BioTech 365

Titan Medical Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule Titan Medical Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule TORONTO, June 29, 2022 (GLOBE NEWSWIRE) — Titan Medical Inc.

Global Sterile Filtration for Life Science Market to 2027 – Need for Regulatory Compliance Presents Opportunities – ResearchAndMarkets.com

BioTech 365

Global Sterile Filtration for Life Science Market to 2027 – Need for Regulatory Compliance Presents Opportunities – ResearchAndMarkets.com Global Sterile Filtration for Life Science Market to 2027 – Need for Regulatory Compliance Presents Opportunities – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Sterile Filtration … Continue reading → Business Wire

10th Annual Legal, Regulatory & Compliance Forum on Dietary Supplements is Just Days Away

FDA Law Blog

Karst — The American Conference Institute and Council for Responsible Nutrition are hosting the 10th Annual Legal, Regulatory & Compliance Forum on Dietary Supplements live in New York next week, June 29-30. By Kurt R.

MEDIROM Healthcare Technologies Inc. Regains Compliance with Nasdaq Listing Standard

BioTech 365

Regains Compliance with Nasdaq Listing Standard MEDIROM Healthcare Technologies Inc. Regains Compliance with Nasdaq Listing Standard NEW YORK, April 22, 2022 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. MEDIROM Healthcare Technologies Inc. Nasdaq CM: MRM), a holistic healthcare company based … Continue reading → GlobeNewswire

Nutra Pharma Provides Business and Compliance Updates

BioTech 365

Nutra Pharma Provides Business and Compliance Updates Nutra Pharma Provides Business and Compliance Updates Nutra Pharma is providing updates regarding their business plans, accounting and compliance Plantation, Florida, July 26, 2021 (GLOBE NEWSWIRE) — Nutra Pharma Corporation (OTC Pink: NPHC), … Continue reading → GlobeNewswire

Anne Walsh to Moderate FDLI Compliance and Enforcement Panel

FDA Law Blog

s Anne Walsh will be moderating “Updates in Litigation Risks: Product Liability, Private Litigation, and Consumer Class Actions,” at the upcoming Food and Drug Law Institute’s Enforcement, Litigation, and Compliance Conference on December 9-10. Hyman, Phelps & McNamara, P.C.’s

Three Day Virtual Pharmaceutical SOP Writing, Training and Compliance Course, July 25-26, 2022 – ResearchAndMarkets.com

BioTech 365

Three Day Virtual Pharmaceutical SOP Writing, Training and Compliance Course, July 25-26, 2022 – ResearchAndMarkets.com Three Day Virtual Pharmaceutical SOP Writing, Training and Compliance Course, July 25-26, 2022 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “SOP Writing, Training and Compliance in the Pharmaceutical … Continue reading → Business Wire

Hand Hygiene Compliance Rate During the COVID-19 Pandemic

JAMA Internal Medicine

This quality improvement study assesses hand hygiene compliance rates in a hospital with an automated hand hygiene monitoring system during the COVID-19 pandemic

 Opentrons Labworks, Inc. Appoints Chief Financial Officer, and Chief Legal and Compliance Officer

BioTech 365

Appoints Chief Financial Officer, and Chief Legal and Compliance Officer Opentrons Labworks, Inc. Appoints Chief Financial Officer, and Chief Legal and Compliance Officer LONG ISLAND CITY, N.Y.–(BUSINESS Opentrons Labworks, Inc.

Johnson & Quin Achieves HIPAA Security Compliance Assessment

BioTech 365

Johnson & Quin Achieves HIPAA Security Compliance Assessment Johnson & Quin Achieves HIPAA Security Compliance Assessment NILES, Ill.–(BUSINESS –(BUSINESS WIRE)–#colorinkjet—Johnson & Quin, a full-service direct mail production and mailing services company, has successfully achieved the HIPAA Security Compliance Assessment which certifies … Continue reading → Business Wire

Tiziana Life Sciences Ltd. Announces Annual Report Filed to Regain Nasdaq Compliance

BioTech 365

Announces Annual Report Filed to Regain Nasdaq Compliance Tiziana Life Sciences Ltd. Announces Annual Report Filed to Regain Nasdaq Compliance Form 20-F Filed on May 23, 2022 Following Receipt of Notice from Nasdaq Regarding Filing Deadline … Continue reading → GlobeNewswireTiziana Life Sciences Ltd.

Sharps Compliance Announces Change to Board of Directors

BioTech 365

Sharps Compliance Announces Change to Board of Directors Sharps Compliance Announces Change to Board of Directors HOUSTON, May 24, 2021 (GLOBE NEWSWIRE) — Sharps Compliance Corp. NASDAQ: SMED) (“Sharps Compliance” or the “Company”), a leading full-service national provider of comprehensive … Continue reading → GlobeNewswire

Sharps Compliance Corp. Announces Proposed Public Offering of Common Stock

BioTech 365

Sharps Compliance Corp. Announces Proposed Public Offering of Common Stock Sharps Compliance Corp. 25, 2021 (GLOBE NEWSWIRE) — Sharps Compliance Corp. Announces Proposed Public Offering of Common Stock HOUSTON, Aug. Nasdaq: SMED), a full service provider of waste management, today … Continue reading → GlobeNewswire

Experts to come together for compliance event ‘validation ready’ global labeling systems  

Pharma Phorum

Experts to come together for compliance event . This one-hour event is particularly suited to those in industry roles such as compliance, regulatory affairs and quality assurance, or anyone who needs to understand what best practice looks like in a global labeling system.

Politicized pandemic shaped compliance with social distancing

Scienmag

Study: Opposing messages, personal beliefs influenced behavior COLUMBUS, Ohio – Politicization of the COVID-19 pandemic had a powerful influence over adherence to social distancing guidelines in the United States and why people did, or did not, comply during the lockdown days, a new study has found. The analysis boiled down to whom study participants trusted […].

Cognito Therapeutics Appoints Jennifer Newberger as Head of Regulatory and Compliance

BioTech 365

Cognito Therapeutics Appoints Jennifer Newberger as Head of Regulatory and Compliance Cognito Therapeutics Appoints Jennifer Newberger as Head of Regulatory and Compliance CAMBRIDGE, Mass.–(BUSINESS

Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq

BioTech 365

Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq BLOOMFIELD HILLS, Mich.–(BUSINESS –(BUSINESS WIRE)–ZIVO Bioscience, Inc. NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development … Continue reading → Business Wire

Sharps Compliance To Present at ROTH Virtual London Conference

BioTech 365

Sharps Compliance To Present at ROTH Virtual London Conference Sharps Compliance To Present at ROTH Virtual London Conference HOUSTON, June 16, 2021 (GLOBE NEWSWIRE) — Sharps Compliance Corp. Nasdaq: SMED) announced today that David P. Tusa, President and Chief Executive … Continue reading → GlobeNewswire

Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)

BioTech 365

Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) Allarity Therapeutics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) Cambridge, MA U.S.A. April 22, 2022) — Allarity Therapeutics, Inc. Nasdaq: ALLR) (“Allarity” or the “Company”), a clinical-stage … Continue reading → GlobeNewswire

Legacy Health Selects Wolters Kluwer to Standardize Medication Compounding and Ensure USP Compliance Across Eight Locations

BioTech 365

Legacy Health Selects Wolters Kluwer to Standardize Medication Compounding and Ensure USP Compliance Across Eight Locations Legacy Health Selects Wolters Kluwer to Standardize Medication Compounding and Ensure USP Compliance Across Eight Locations Simplifi 797 supports the health system’s initiative to … Continue reading → Business Wire

Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada

BioTech 365

Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada TORONTO and CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today … Continue reading → GlobeNewswire

Christopher Phillips Named Chair of the BioUtah Regulatory, Compliance and Quality Committee

BioTech 365

Christopher Phillips Named Chair of the BioUtah Regulatory, Compliance and Quality Committee Christopher Phillips Named Chair of the BioUtah Regulatory, Compliance and Quality Committee Fluidx’s regulatory and clinical affairs director will take the reins of the Regulatory, Compliance and Quality … Continue reading → Business Wire

Aeterna Zentaris Regains Compliance with Nasdaq Minimum Bid Price Requirement

BioTech 365

Aeterna Zentaris Regains Compliance with Nasdaq Minimum Bid Price Requirement Aeterna Zentaris Regains Compliance with Nasdaq Minimum Bid Price Requirement CHARLESTON, S.C., March 22, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a … Continue reading → GlobeNewswire

AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement

BioTech 365

AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement SAN JOSE, Calif., March 05, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., AnPac Bio,” the “Company” or “we”) (ANPC), a … Continue reading → GlobeNewswire

Regulatory Compliance Coverage & Reference between FDA 21 CFR Part 11 and EU Annex 11

Cloudbyz

To ensure continued compliance to these regulations, it is imperative for clinical researchers to understand the similarities and differences between these regulations. Until recently, clinical trials have been performed in a mostly paper-based processes.

Regulatory Compliance Coverage & Reference between FDA 21 CFR Part 11 and EU Annex 11

Cloudbyz

To ensure continued compliance to these regulations, it is imperative for clinical researchers to understand the similarities and differences between these regulations Until recently, clinical trials have been performed in a mostly paper-based processes.

Ocugen Inc. Regains Compliance with Nasdaq Bid Price Rule

BioTech 365

Regains Compliance with Nasdaq Bid Price Rule Ocugen Inc. Regains Compliance with Nasdaq Bid Price Rule MALVERN, Pa., Ocugen Inc. 08, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene … Continue reading → GlobeNewswire

Sharps Compliance Corp. Closes $17.9 Million Underwritten Public Offering of Common Stock

BioTech 365

Sharps Compliance Corp. Million Underwritten Public Offering of Common Stock Sharps Compliance Corp. 30, 2021 (GLOBE NEWSWIRE) — Sharps Compliance Corp. Closes $17.9 Closes $17.9 Million Underwritten Public Offering of Common Stock HOUSTON, Aug. Nasdaq: SMED) (the “Company”) today announced … Continue reading → GlobeNewswire

Outlook Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

BioTech 365

Outlook Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement Outlook Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement MONMOUTH JUNCTION, N.J., 01, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the … Continue reading → GlobeNewswire

Sharps Compliance Corp. Prices $15.6 Million Underwritten Public Offering of Common Stock

BioTech 365

Sharps Compliance Corp. Million Underwritten Public Offering of Common Stock Sharps Compliance Corp. 25, 2021 (GLOBE NEWSWIRE) — Sharps Compliance Corp. Prices $15.6 Prices $15.6 Million Underwritten Public Offering of Common Stock HOUSTON, Aug. Nasdaq: SMED) (the “Company”) today announced … Continue reading → GlobeNewswire

Two Day Pharmaceutical SOP Writing, Training and Compliance Online Course, October 25th-26th, 2021 – ResearchAndMarkets.com

BioTech 365

Two Day Pharmaceutical SOP Writing, Training and Compliance Online Course, October 25th-26th, 2021 – ResearchAndMarkets.com Two Day Pharmaceutical SOP Writing, Training and Compliance Online Course, October 25th-26th, 2021 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “SOP Writing, Training and Compliance in the Pharmaceutical … Continue reading → Business Wire

ICON Launches FIRECREST Safety Letters and Site Question Management Supporting Regulatory Compliance and Increasing Site Support

BioTech 365

Neovasc Granted Additional 180 Calendar Day Grace Period for Nasdaq Bid Price Compliance

BioTech 365

Neovasc Granted Additional 180 Calendar Day Grace Period for Nasdaq Bid Price Compliance Neovasc Granted Additional 180 Calendar Day Grace Period for Nasdaq Bid Price Compliance VANCOUVER and MINNEAPOLIS, Nov. 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the … Continue reading → GlobeNewswire

Dalrada Corporation’s Pala Diagnostics Free COVID-19 Point-of-care Tests Proved Compliance for Nearly 3,000 Outdoor Festival Attendees

BioTech 365